<DOC>
	<DOCNO>NCT00004032</DOCNO>
	<brief_summary>Phase I trial study effectiveness tumor cell vaccine interferon gamma patient refractory epithelial ovarian cancer . Vaccines make person 's cancer cell may make body build immune response kill tumor cell . Combining vaccine therapy interferon gamma may effective treatment epithelial ovarian cancer</brief_summary>
	<brief_title>Tumor Vaccine Interferon Gamma Treating Patients With Refractory Epithelial Ovarian Cancer</brief_title>
	<detailed_description>OBJECTIVES : I . Determine whether intraperitoneal ( IP ) injection epithelial ovarian carcinoma cell infect ALVAC-hB7.1 IP interferon gamma acceptable toxicity produce clinical response patient refractory ovarian epithelial cancer . OUTLINE : This dose-escalation study ALVAC-hB7.1 infect tumor cell . Patients receive ALVAC-hB7.1 infect tumor cell intraperitoneally ( IP ) day 4 , 11 , 18 . Patients also receive interferon gamma IP day 8 , 10 , 15 , 17 . In absence disease progression , 6 course therapy may give . If insufficient tumor cell available continue treatment tumor cell derive vaccine , interferon gamma may give alone . Cohorts 3 6 patient receive escalate dos ALVAC-hB7.1 infect tumor cell maximum tolerate dose ( MTD ) determine . The MTD define dose 2 6 patient experience dose-limiting toxicity . Patients follow every 6 month disease progression . PROJECTED ACCRUAL : A total 12 patient accrue study .</detailed_description>
	<mesh_term>Ovarian Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Glandular Epithelial</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<mesh_term>Interferons</mesh_term>
	<mesh_term>Interferon-gamma</mesh_term>
	<criteria>Diagnosis ovarian epithelial carcinoma Previously treat adequate course platinum base chemotherapy Evidence intraabdominal disease No significant adhesion Performance status Zubrod 02 Lymphocyte count least 500/mm^3 Bilirubin great 1.5 mg/dL SGOT le 2.5 time upper limit normal Creatinine great 1.5 mg/dL No major disorder cardiovascular system No major disorder pulmonary system Not pregnant nursing Fertile patient must use effective contraception Successful placement peritoneal catheter No overt autoimmune disease No concurrent chronic steroid therapy No prior radiotherapy Prior surgery allow Recovered prior therapy</criteria>
	<gender>Female</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2013</verification_date>
</DOC>